Annika Dejmek (Former)
21 – 30 of 32
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2007
-
Mark
Comparison of NCL-hTERT antibody reactivity and telomere repeat amplification protocol in situ in effusions
(
- Contribution to journal › Article
-
Mark
Lower proliferation rate in metastatic effusion mesothelial cells than in benign effusions.
(
- Contribution to journal › Article
-
Mark
No detection of SV40 DNA in mesothelioma tissues from a high incidence area in Sweden.
(
- Contribution to journal › Article
-
Mark
Weak telomerase activity in malignant cells in metastatic serous effusions - Correlation to short survival time
(
- Contribution to journal › Article
-
Mark
The proliferation rates in mesothelial cells in effusions also containing metastatic cells are lower than in benign effusions
(
- Contribution to journal › Article
- 2006
-
Mark
The reactivity to CK5/6 antibody in tumor cells from non-small cell lung cancers shed into pleural effusions predicts survival.
(
- Contribution to journal › Article
- 2005
-
Mark
The combination of CEA, EMA, and BerEp4 and hyaluronan analysis specifically identifies 79% of all histologically verified mesotheliomas causing an effusion.
(
- Contribution to journal › Article
-
Mark
Telomere repeat amplification protocol (TRAP in situ reveals telomerase activity in three cell types in effusions: malignant cells, proliferative mesothelial cells, and lymphocytes
(
- Contribution to journal › Article
-
Mark
Wnt-5a protein expression in primary dukes B colon cancers identifies a subgroup of patients with good prognosis.
(
- Contribution to journal › Article
- 2003
-
Mark
Fine needle aspiration cytology of an ovarian luteinized follicular cyst mimicking a granulosa cell tumor. A case report.
(
- Contribution to journal › Article